Jack joined Consilium Strategic Communications as an Account Executive in October 2022, having been previously involved with clinical trial approvals and amendments at the NHS Health Research Authority since December 2016 (including CTIMPs, phase 1 studies in healthy volunteers, phase 1 studies in patients, and fast-track studies).

Born and raised in Newcastle-upon-Tyne, Jack recently graduated from the University of Cambridge with a first class honours MPhil in History and Philosophy of Science and Medicine, specialising in bioethics, clinical research ethics, and philosophy of medicine. Research topics included: personal agency in advance euthanasia directives, the epistemology of informed consent and undue inducement in clinical trial recruitment, and the ‘nocebo’ effect in relation to patient autonomy and non-maleficence in side effect disclosure. Additionally, Jack holds a first class honours BSc in Politics and Philosophy from the London School of Economics and Political Science.

Back to team